Acetaldehyde accumulation
Acetaldehyde is the Group-1 carcinogen produced when the liver metabolizes ethanol, and a major driver of acute symptoms during the clearance window. In non-ALDH2*2 livers it's cleared rapidly by ALDH2; the morning-after symptoms most people attribute to acetaldehyde are usually downstream sequelae — NAD⁺ depletion, glutathione exhaustion, sleep architecture damage — that persist after the acetaldehyde itself is gone. This page covers the active clearance window when acetaldehyde is in circulation.
What is happening
The metabolic pipeline
Ethanol → (ADH) → acetaldehyde → (ALDH2) → acetate → (TCA cycle) → CO₂ + H₂O.
The first step is fast. The second step is the bottleneck. Acetaldehyde sits in the middle, waiting for ALDH2 to clear it, and its concentration climbs whenever ADH feeds it faster than ALDH2 can drain it.
Ingredients that address this, ranked
- NAC (N-Acetyl Cysteine) Tier 1 · Core Impact: high — Glutathione precursor protecting ALDH2's catalytic Cys302; acetaminophen safety net.
- Sulforaphane Tier 1 · Core Impact: high — Nrf2 activator; pre-induces ALDH2 transcription. Preflight only.
- Nicotinamide Riboside (NR) Tier 1 · Core Impact: high — Restores the NAD⁺ ALDH2 needs as a cofactor; the rate-limiter for clearance.
- L-Cysteine Tier 2 · Strong Impact: medium — GSH substrate; secondary local trap in oral and gastric compartments only.
- DHM (Dihydromyricetin) Tier 2 · Strong Impact: medium — ADH/ALDH2 acceleration in rodents; blunts GABA rebound. Human RCT evidence is mixed.
- Glycine Tier 2 · Strong Impact: medium — Second sacrificial-amine trap; paired with cysteine in local compartments.
How tiers compare for this mechanism
| Goal | Best (Tier 1) | Strong support (Tier 2) | Situational (Tier 3+) |
|---|---|---|---|
| Acetaldehyde clearance | NAC, Sulforaphane (preflight only), NR | L-Cysteine, DHM, Glycine | |
| Glutathione support | NAC, Sulforaphane, NR | L-Cysteine | |
| Liver protection | NAC, Sulforaphane, NR | L-Cysteine, DHM, Silymarin | |
| Neurotransmitter modulation | DHM, Magnesium glycinate, Glycine |
Deeper science · In more detail
Why it is so reactive
Acetaldehyde has an electrophilic carbonyl carbon that readily forms covalent adducts with nucleophiles in the body:
- Proteins — attacks lysine ε-amines, producing Schiff bases that crosslink hepatic proteins.
- DNA — forms N²-ethylidene-deoxyguanosine adducts (the carcinogenic mechanism).
- Glutathione — depletes the tripeptide that normally quenches electrophiles, undermining the backup defense.
How the protocol attacks it
The four-layer architecture, ordered by share of bulk clearance:
- Layer 1 — Enzymatic clearance (the primary pathway). ALDH2 does ~95% of the work in non-ALDH2*2 livers. NAD⁺ is its rate-limiting cofactor; SIRT3 (NAD⁺-dependent) deacetylates and activates it. NR/NMN supports both.
- Layer 2 — Local chemical trapping (limited reach at oral doses). Sulfur and amine nucleophiles (cysteine, glycine) form covalent adducts with acetaldehyde. At swallowed-capsule doses this matters in saliva, gastric lumen, and hepatic portal flux only — not bulk plasma. For meaningful oral/gastric trapping, slow-release formats are required (Acetium-class).
- Layer 3 — Liver infrastructure (the resilience layer). Glutathione protects ALDH2's catalytic Cys302 from auto-inactivation by acetaldehyde itself. NAC, sulforaphane, silymarin.
- Layer 4 — Pre-induction (the lead-time play). Sulforaphane via Nrf2 upregulates ALDH2 expression hours before exposure. Preflight only.